Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

1a,25-(OH)2D3

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 10 USDMF, 7 CEP/COS, 3 JDMF, 2 EU WC, 4 KDMF, 5 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

138 FDF Dossiers, 37 FDA Orange Book, 59 Europe, 8 Canada, 16 Australia, 1 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Kirsch Pharma, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 CD Formulation, 1 Finar, 3 Gangwal Chemicals, 1 Gloria Interchem, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders, 23 Parenteral, 17 Taste Masking, 16 Chewable & Orodispersible Aids, 14 Direct Compression, 12 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 8 Solubilizers, 8 Empty Capsules, 8 Topical, 6 Coating Systems & Additives, 6 Thickeners and Stabilizers, 6 Co-Processed Excipients, 4 Granulation, 3 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 34 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

10 APIs, 13 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/03/2026	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 1998-055 - Rev 09	Calcitriol	2025-11-06	Valid	Chemical		883
31/03/2026	CARBOGEN AMCIS AG	Switzerland	CARBOGEN AMCIS B.V. Veenendaal NL	CEP 1996-009 - Rev 14	Calcitriol	2026-03-20	Valid	Chemical and TSE		883

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

1a,25-(OH)2D3

1a,25-(OH)2D3

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers

10 USDMF

7 CEP/COS

3 JDMF

2 EU WC

4 KDMF

5 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

138 FDF Dossiers

37 FDA Orange Book

59 Europe

8 Canada

16 Australia

1 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

17 SPI Pharma

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

7 Kirsch Pharma

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

1 CD Formulation

1 Finar

3 Gangwal Chemicals

1 Gloria Interchem

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

2 Microlex e.U

3 Pluviaendo

1 Qualicaps

19 Roquette

4 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders

23 Parenteral

17 Taste Masking

16 Chewable & Orodispersible Aids

14 Direct Compression

12 Film Formers & Plasticizers

10 Disintegrants & Superdisintegrants

8 Solubilizers

8 Empty Capsules

8 Topical

6 Coating Systems & Additives

6 Thickeners and Stabilizers

6 Co-Processed Excipients

4 Granulation

3 Surfactant & Foaming Agents

2 Emulsifying Agents

1 API Stability Enhancers

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons